"BON’s news blitz reads like a biotech fever dream—postbiotics, broccoli sleep aids, and a $45M broccoli order?! 🥦🚀 But Nasdaq delisting looms like a dark cloud. Technically, the stock’s a rollercoaster: 9-period WMA dipping below 21-period (uh-oh), RSI stuck in the 30s (oversold but not screaming buy), and today’s wild volume spike smells like desperation. If you’re a gambler, maybe catch the bounce. Otherwise, this feels like a ‘hold and watch the circus’ stock. #HighRiskLowSleep"

The given stock data indicates a dramatic bullish trend for Bon Natural Life Limited over the last 24 hours. The stock price saw an impressive jump from as low as $0.735 to a peak around $2.72 and later market corrections brought it down to $1.37. This movement points toward high volatility, which is also underscored by substantial trading volumes especially during the price surges; a possible signal of mass buying from the investors. Aiming for short-term gains, day traders seem to be capitalizing on the bullish volatility. The company has been in the news for several positive updates such as strategic brand partnerships, breakthrough in Apple Polyphenol Technology, a hefty broccoli product deal, and record first half-year revenue. These updates could be significant catalysts for the tremendous upward price movement. However, also noteworthy is the company's announcement of a NASDAQ notification regarding independent board requirement. While other details about this issue are not known, it might cause some worry and partially explain the stock price correction. Considering these factors, traders should observe future news, business updates and market trends carefully to make informed decisions. The key support and resistance levels seem to be around $1.2 and $2.25 respectively.